Quarterly report · Q2
3583.TEDINET S100PIIF
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥341m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥366m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥366m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥363m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥405m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥365m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥270m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥537m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥252m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥270m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥252m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥9.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥9.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥190m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥649m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥189m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥47m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥114m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥266m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥97.39 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.08 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.04 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.19 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.71 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥344,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥4m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥696m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥693m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥44m |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥451m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥495m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥491m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥14m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥697m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥695m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥77m |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥449m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥527m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥513m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholders equity | Prior1YearInstant | 5355068000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 5488058000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 35651000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 40824000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | -39249000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | 27151000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 65005000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 86125000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 61407000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 154100000 | JPY |
| Net assets | Prior1YearInstant | 5416476000 | JPY |
| Net assets | CurrentQuarterInstant | 5642159000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 9441206000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 9440810000 | JPY |
| Net sales | Prior1YTDDuration | 2706753000 | JPY |
| Net sales | CurrentYTDDuration | 2658520000 | JPY |
| Cost of sales | Prior1YTDDuration | 1746931000 | JPY |
| Cost of sales | CurrentYTDDuration | 1682148000 | JPY |
| Gross profit | Prior1YTDDuration | 959822000 | JPY |
| Gross profit | CurrentYTDDuration | 976371000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 593595000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 635062000 | JPY |
| Operating income | Prior1YTDDuration | 366226000 | JPY |
| Operating income | CurrentYTDDuration | 341308000 | JPY |
| Interest income noi | Prior1YTDDuration | 243000 | JPY |
| Interest income noi | CurrentYTDDuration | 284000 | JPY |
| Dividends income noi | Prior1YTDDuration | 1481000 | JPY |
| Dividends income noi | CurrentYTDDuration | 2217000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 2504000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 28973000 | JPY |
| Other noi | Prior1YTDDuration | 2027000 | JPY |
| Other noi | CurrentYTDDuration | 3178000 | JPY |
| Non operating income | Prior1YTDDuration | 6257000 | JPY |
| Non operating income | CurrentYTDDuration | 34653000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 7563000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 6812000 | JPY |
| Other noe | Prior1YTDDuration | 2034000 | JPY |
| Other noe | CurrentYTDDuration | 2756000 | JPY |
| Non operating expenses | Prior1YTDDuration | 9598000 | JPY |
| Non operating expenses | CurrentYTDDuration | 9569000 | JPY |
| Ordinary income | Prior1YTDDuration | 362885000 | JPY |
| Ordinary income | CurrentYTDDuration | 366393000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 2267000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 61968000 | JPY |
| Extraordinary income | Prior1YTDDuration | 2267000 | JPY |
| Extraordinary income | CurrentYTDDuration | 61968000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | - | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 22868000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 6000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 47000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |